X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12353) 12353
Book Review (3815) 3815
Newspaper Article (2483) 2483
Newsletter (1524) 1524
Publication (933) 933
Trade Publication Article (193) 193
Book Chapter (122) 122
Web Resource (113) 113
Magazine Article (93) 93
Book / eBook (77) 77
Transcript (47) 47
Conference Proceeding (37) 37
Dissertation (6) 6
Report (3) 3
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9785) 9785
humans (9528) 9528
lymphomas (7686) 7686
oncology (5573) 5573
female (4458) 4458
cancer (4433) 4433
male (4380) 4380
hematology (4310) 4310
middle aged (3825) 3825
adult (3245) 3245
aged (3221) 3221
chemotherapy (3087) 3087
rituximab (2902) 2902
lymphoma (2749) 2749
care and treatment (2622) 2622
non-hodgkins-lymphoma (2502) 2502
antineoplastic combined chemotherapy protocols - therapeutic use (2264) 2264
non-hodgkin's lymphomas (2212) 2212
treatment outcome (1939) 1939
leukemia (1916) 1916
research (1894) 1894
follicular lymphoma (1779) 1779
b-cell lymphoma (1667) 1667
prognosis (1653) 1653
antineoplastic agents - therapeutic use (1624) 1624
drug therapy (1543) 1543
lymphoma, follicular - drug therapy (1418) 1418
animals (1416) 1416
clinical trials (1402) 1402
aged, 80 and over (1352) 1352
chronic lymphocytic-leukemia (1346) 1346
therapy (1323) 1323
lymphoma, non-hodgkin - drug therapy (1252) 1252
patients (1243) 1243
antibodies, monoclonal - therapeutic use (1185) 1185
immunotherapy (1150) 1150
medicine & public health (1137) 1137
cancer therapies (1108) 1108
tumors (1098) 1098
health aspects (1087) 1087
apoptosis (1075) 1075
antibodies, monoclonal, murine-derived (1013) 1013
medical research (1007) 1007
transplantation (993) 993
antineoplastic agents (992) 992
pharmaceutical industry (981) 981
analysis (977) 977
antimitotic agents (962) 962
survival (926) 926
immunology (920) 920
disease-free survival (899) 899
retrospective studies (835) 835
hemic and lymphatic diseases (816) 816
adolescent (812) 812
cyclophosphamide - administration & dosage (794) 794
fda approval (788) 788
stem cells (779) 779
abridged index medicus (771) 771
t cells (771) 771
diagnosis (766) 766
risk factors (744) 744
neoplasm staging (730) 730
pathology (727) 727
disease (725) 725
expression (721) 721
lymphoma, large b-cell, diffuse - drug therapy (720) 720
lymphoma, b-cell - drug therapy (710) 710
combined modality therapy (692) 692
antineoplastic combined chemotherapy protocols - administration & dosage (676) 676
lymphocytes (676) 676
monoclonal antibodies (675) 675
lymphoma, follicular - pathology (670) 670
cyclophosphamide (662) 662
young adult (659) 659
hematology, oncology and palliative medicine (653) 653
non-hodgkin's lymphoma (645) 645
pharmacology & pharmacy (643) 643
anti-cd20 monoclonal-antibody (640) 640
follow-up studies (640) 640
vincristine - administration & dosage (635) 635
mice (629) 629
antineoplastic combined chemotherapy protocols - adverse effects (626) 626
recurrence (613) 613
studies (608) 608
survival analysis (595) 595
genetic aspects (594) 594
doxorubicin - administration & dosage (590) 590
survival rate (588) 588
medicine, experimental (584) 584
remission induction (582) 582
gene expression (574) 574
proteins (572) 572
multiple myeloma (569) 569
antibodies, monoclonal - administration & dosage (565) 565
lymphoma, non-hodgkin - pathology (559) 559
cell line, tumor (557) 557
drug dosages (545) 545
non-hodgkin-lymphoma (544) 544
non-hodgkin lymphoma (543) 543
prednisone - administration & dosage (543) 543
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (54) 54
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16676) 16676
Japanese (78) 78
German (71) 71
French (58) 58
Spanish (29) 29
Chinese (21) 21
Russian (14) 14
Polish (10) 10
Czech (9) 9
Italian (5) 5
Hungarian (4) 4
Korean (4) 4
Dutch (2) 2
Portuguese (2) 2
Croatian (1) 1
Danish (1) 1
Finnish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9759, pp. 42 - 51
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1331 - 1344
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2008, Volume 26, Issue 32, pp. 5156 - 5164
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2015, Volume 33, Issue 23, pp. 2516 - 2522
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 424 - 435
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 26, pp. 3272 - 3278
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 1, pp. 69 - 77
Journal Article
Annals of Oncology, ISSN 1569-8041, 03/2013, Volume 24, Issue 3, pp. 561 - 76
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2014, Volume 32, Issue 28, pp. 3096 - 3102
Journal Article
Journal Article
Nature, ISSN 0028-0836, 12/2012, Volume 491, Issue 7427, pp. 108 - 112
In eukaryotes, post-translational modification of histones is critical for regulation of chromatin structure and gene expression. EZH2 is the catalytic subunit... 
LYSINE 27 | METHYLATION | MULTIDISCIPLINARY SCIENCES | B-CELL LYMPHOMAS | GENES | HISTONE METHYLTRANSFERASE EZH2 | H3K27 | HYPERTRIMETHYLATION | SOMATIC MUTATIONS | HUMAN CANCER | Polycomb Repressive Complex 2 - antagonists & inhibitors | Neoplasm Transplantation | Gene Silencing - drug effects | Lymphoma, Follicular - drug therapy | Polycomb Repressive Complex 2 - genetics | Histones - chemistry | Humans | Transcriptional Activation - drug effects | Transplantation, Heterologous | Histone-Lysine N-Methyltransferase - antagonists & inhibitors | Lymphoma, Follicular - genetics | Indoles - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Repressor Proteins - metabolism | Histone-Lysine N-Methyltransferase - genetics | Repressor Proteins - chemistry | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Lymphoma, Large B-Cell, Diffuse - enzymology | Mutation - genetics | Enhancer of Zeste Homolog 2 Protein | Animals | Histone-Lysine N-Methyltransferase - metabolism | Methylation - drug effects | Cell Line, Tumor | Indoles - therapeutic use | Lymphoma, Follicular - enzymology | Cell Proliferation - drug effects | Mice | Pyridones - therapeutic use | Histones - metabolism | Polycomb Repressive Complex 2 - metabolism | Lymphoma, Large B-Cell, Diffuse - genetics | Pyridones - pharmacology | Gene mutations | Methyltransferases | Physiological aspects | Lymphomas | Genetic aspects | Research | Health aspects | Risk factors | Care and treatment | Proteins | Cell growth | Cytotoxicity | Mutation | Gene expression | Laboratory animals | Tumors | Apoptosis | Index Medicus
Journal Article